Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
CytoDyn Inc. (CYDY) had Return on Equity of -3.90% for the most recently reported fiscal year, ending 2025-05-31.
| Income Statement Financials | |
-- |
|
$3.75M |
|
-- |
|
-- |
|
$-9.66M |
|
$9.66M |
|
$-5.92M |
|
$3.75M |
|
$3.34M |
|
$3.75M |
|
$3.75M |
|
$3.75M |
|
$3.34M |
|
$9.66M |
|
$10.09M |
|
1.21B |
|
1.24B |
|
$0.00 |
|
$0.00 |
|
| Balance Sheet Financials | |
$17.88M |
|
-- |
|
$0.17M |
|
$18.05M |
|
$70.52M |
|
-- |
|
$43.57M |
|
$114.09M |
|
$-96.04M |
|
$-96.04M |
|
$-96.04M |
|
1.25B |
|
| Cash Flow Statement Financials | |
$-8.77M |
|
-- |
|
$10.85M |
|
$9.81M |
|
$11.90M |
|
$2.09M |
|
$1.61M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.25 |
|
-- |
|
-- |
|
-- |
|
-0.28 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-8.77M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
-3.90% |
-3.90% |
|
20.75% |
|
-3.90% |
|
$-0.08 |
|
$-0.01 |
|
$-0.01 |
|